DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Green BD, Mooney MH, Gault VA. et al.
Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39).
Metabolism 2004;
53: 252-259
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.